We are live on ! Find out more
SYK icon

Stryker

329.67 USD
-0.92
0.28%
At close Updated Aug 26, 4:00 PM EDT
Pre-market
After hours
329.06
-0.61
0.19%
1 day
-0.28%
5 days
-2.54%
1 month
-2.1%
3 months
5.33%
6 months
-14.61%
Year to date
-5.32%
1 year
-16.4%
5 years
21.58%
10 years
188.07%
 

About: Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Employees: 56,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 65.9%
Neutral 27.3%
Negative 6.8%
Neutral
Zacks Investment Research
16 hours ago
Do Options Traders Know Something About Stryker Stock We Don't?
Investors need to pay close attention to SYK stock based on the movements in the options market lately.
Do Options Traders Know Something About Stryker Stock We Don't?
Positive
Zacks Investment Research
5 days ago
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
SYK's resilient demand, Mako robotics growth and margin gains support its outlook despite cyber and supply disruptions.
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Positive
Seeking Alpha
6 days ago
Stryker: The Sell-Off Creates A Better Entry Point, But Q2 Wasn't Perfect
Stryker (SYK) rebounded in Q2 with 9% organic growth, restoring confidence after a weak Q1. Both MedSurg & Neurotech and Orthopaedics segments sharply accelerated, indicating Q1 weakness was temporary. Guidance was modestly adjusted, but demand remains strong and growth is broad-based across product lines.
Stryker: The Sell-Off Creates A Better Entry Point, But Q2 Wasn't Perfect
Positive
Zacks Investment Research
12 days ago
SYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend?
Stryker has gained 3.8% since March-end as Mako robotics, hospital capital demand and international growth drive momentum.
SYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend?
Positive
Zacks Investment Research
13 days ago
Is SYK Worth Buying as Growth Improves but Execution Risks Persist?
Stryker's stronger growth, margin gains and product pipeline support the case, but cyber costs, supply constraints and acquisition execution keep risks elevated.
Is SYK Worth Buying as Growth Improves but Execution Risks Persist?
Positive
Zacks Investment Research
13 days ago
Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?
Stryker enters the second half with Q2 momentum restored, but meeting guidance hinges on production, backlog conversion and managing cyber and supply risks.
Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?
Positive
Zacks Investment Research
13 days ago
Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?
Stryker's 13.6% three-month rally reflects stronger sales, margins and production, but execution risks and a premium peer valuation could test further gains.
Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?
Neutral
Seeking Alpha
13 days ago
American Century Focused Global Growth Fund Q2 2026 Commentary
Key Contributors include Palo Alto Networks, ASML Holding, and Taiwan Semiconductor. Key Detractors include Micron Technology, AIA Group, and BAE Systems. Notable Trades include AMD, BrightSpring Health, AbbVie, and Stryker.
American Century Focused Global Growth Fund Q2 2026 Commentary
Positive
Zacks Investment Research
14 days ago
PBH or SYK: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
PBH or SYK: Which Is the Better Value Stock Right Now?
Neutral
GlobeNewsWire
21 days ago
Stryker declares an $0.88 per share quarterly dividend
Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.
Stryker declares an $0.88 per share quarterly dividend
Price charts implemented using Lightweight Charts™